Literature DB >> 89500

Plasma-exchange combined with immunosuppressive therapy in myasthenia gravis.

P O Behan, R A Shakir, J A Simpson, A K Burnett, T L Allan, G Haase.   

Abstract

Twenty-one patients with myasthenia gravis underwent a course of plasma exchange combined with immunosuppressive therapy. In fifteen there was dramatic clinical improvement which has been maintained for periods up to 19 months. Nine of these patients now take no anticholinesterase drugs. Six patients had a recurrence 3--9 months after the first course but in the three given a second course remissions were again obtained.

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 89500     DOI： 10.1016/s0140-6736(79)91492-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


  10 in total

Review 1.  Immunopathology of acetylcholine receptors in myasthenia gravis.

Authors:  M E Seybold; J M Lindstrom
Journal:  Springer Semin Immunopathol       Date:  1982

2.  The effect of chronic daily cyclophosphamide administration on established antibody responses.

Authors:  R F Gagnon; I C MacLennan
Journal:  Clin Exp Immunol       Date:  1981-10       Impact factor: 4.330

3.  Controversies about the treatment of myasthenia gravis.

Authors:  L P Rowland
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-07       Impact factor: 10.154

4.  Plasma exchange and immunosuppressive drug treatment in myasthenia gravis: no evidence for synergy.

Authors:  C J Hawkey; J Newsom-Davis; A Vincent
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-06       Impact factor: 10.154

5.  Patient-specific anti=acetylcholine receptor antibody patterns in myasthenia gravis.

Authors:  T Savage-Marengo; R Harrison; G G Lunt; P O Behan
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-04       Impact factor: 10.154

6.  A short plasma exchange protocol is effective in severe myasthenia gravis.

Authors:  C Antozzi; M Gemma; B Regi; E Berta; P Confalonieri; D Peluchetti; R Mantegazza; F Baggi; M Marconi; F Fiacchino
Journal:  J Neurol       Date:  1991-04       Impact factor: 4.849

7.  Anti-acetylcholine receptor antibody titres in the sera of myasthenia patients treated with plasma exchange combined with immunosuppressive therapy.

Authors:  B Carter; R Harrison; G G Lunt; P O Behan; J A Simpson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-05       Impact factor: 10.154

Review 8.  Paraneoplastic syndromes of the nervous system.

Authors:  G Palma
Journal:  West J Med       Date:  1985-06

9.  Current and emerging treatments for the management of myasthenia gravis.

Authors:  Sivakumar Sathasivam
Journal:  Ther Clin Risk Manag       Date:  2011-07-22       Impact factor: 2.423

Review 10.  Plasma exchange for myasthenia gravis.

Authors:  P Gajdos; S Chevret; K Toyka
Journal:  Cochrane Database Syst Rev       Date:  2002
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.